The client, a global life science company, sought to understand the evolving trends and HCP prescribing behaviors in the immunology market in order to inform and update its brand strategy.
Through secondary research and internal insights and data, Prescient identified how market trends and HCP prescribing behaviors had changed over the past two years.
With an additional analysis of prescription chart audit data, ATU surveys and a thorough audit of available market research, Prescient helped the client understand how recent entrants in the immunology market had changed the treatment paradigm and how patients were segmented, as well as the expected trends in the future years.
Based on these trends, Prescient identified possible future sources of growth and evolving patient segments, which informed segment-specific strategies to drive adoption of our client’s treatment.
Prescient organized and led a cross-functional workshop to create alignment on the current situation and forward-looking priorities.
Results and Solutions
Through this engagement, Prescient elucidated key market trends and emerging patient segments, which informed our client’s strategy to capture new patients and develop its brand.
Prescient’s insights helped guide the focus for a major brand campaign launched by the client that year.